34360581|t|The Slow-Releasing and Mitochondria-Targeted Hydrogen Sulfide (H2S) Delivery Molecule AP39 Induces Brain Tolerance to Ischemia.
34360581|a|Ischemic stroke is the third leading cause of death in the world, which accounts for almost 12% of the total deaths worldwide. Despite decades of research, the available and effective pharmacotherapy is limited. Some evidence underlines the beneficial properties of hydrogen sulfide (H2S) donors, such as NaSH, in an animal model of brain ischemia and in in vitro research; however, these data are ambiguous. This study was undertaken to verify the neuroprotective activity of AP39, a slow-releasing mitochondria-targeted H2S delivery molecule. We administered AP39 for 7 days prior to ischemia onset, and the potential to induce brain tolerance to ischemia was verified. To do this, we used the rat model of 90-min middle cerebral artery occlusion (MCAO) and used LC-MS/MS, RT-PCR, LuminexTM assays, Western blot and immunofluorescent double-staining to determine the absolute H2S levels, inflammatory markers, neurotrophic factor signaling pathways and apoptosis marker in the ipsilateral frontal cortex, hippocampus and in the dorsal striatum 24 h after ischemia onset. AP39 (50 nmol/kg) reduced the infarct volume, neurological deficit and reduced the microglia marker (Iba1) expression. AP39 also exerted prominent anti-inflammatory activity in reducing the release of Il-1beta, Il-6 and TNFalpha in brain areas particularly affected by ischemia. Furthermore, AP39 enhanced the pro-survival pathways of neurotrophic factors BDNF-TrkB and NGF-TrkA and reduced the proapoptotic proNGF-p75NTR-sortilin pathway activity. These changes corresponded with reduced levels of cleaved caspase 3. Altogether, AP39 treatment induced adaptative changes within the brain and, by that, developed brain tolerance to ischemia.
34360581	45	61	Hydrogen Sulfide	Chemical	MESH:D006862
34360581	63	66	H2S	Chemical	MESH:D006862
34360581	86	90	AP39	Chemical	-
34360581	118	126	Ischemia	Disease	MESH:D007511
34360581	128	143	Ischemic stroke	Disease	MESH:D002544
34360581	174	179	death	Disease	MESH:D003643
34360581	237	243	deaths	Disease	MESH:D003643
34360581	394	410	hydrogen sulfide	Chemical	MESH:D006862
34360581	412	415	H2S	Chemical	MESH:D006862
34360581	461	475	brain ischemia	Disease	MESH:D002545
34360581	605	609	AP39	Chemical	-
34360581	650	653	H2S	Chemical	MESH:D006862
34360581	689	693	AP39	Chemical	-
34360581	714	722	ischemia	Disease	MESH:D007511
34360581	777	785	ischemia	Disease	MESH:D007511
34360581	824	827	rat	Species	10116
34360581	844	876	middle cerebral artery occlusion	Disease	MESH:D020244
34360581	878	882	MCAO	Disease	MESH:D020244
34360581	1006	1009	H2S	Chemical	MESH:D006862
34360581	1018	1030	inflammatory	Disease	MESH:D007249
34360581	1185	1193	ischemia	Disease	MESH:D007511
34360581	1201	1205	AP39	Chemical	-
34360581	1231	1238	infarct	Disease	MESH:D007238
34360581	1247	1267	neurological deficit	Disease	MESH:D009461
34360581	1302	1306	Iba1	Gene	29427
34360581	1320	1324	AP39	Chemical	-
34360581	1353	1365	inflammatory	Disease	MESH:D007249
34360581	1402	1410	Il-1beta	Gene	24494
34360581	1412	1416	Il-6	Gene	24498
34360581	1421	1429	TNFalpha	Gene	24835
34360581	1470	1478	ischemia	Disease	MESH:D007511
34360581	1557	1561	BDNF	Gene	24225
34360581	1562	1566	TrkB	Gene	25054
34360581	1571	1574	NGF	Gene	310738
34360581	1575	1579	TrkA	Gene	59109
34360581	1616	1622	p75NTR	Gene	24596
34360581	1623	1631	sortilin	Gene	83576
34360581	1708	1717	caspase 3	Gene	25402
34360581	1731	1735	AP39	Chemical	-
34360581	1833	1841	ischemia	Disease	MESH:D007511
34360581	Association	MESH:D007511	24498
34360581	Association	MESH:D007511	24494
34360581	Association	MESH:D006862	MESH:D002545
34360581	Association	MESH:D007511	24835

